MXPA05012605A - Composiciones que comprenden compuestos de gastrina y sus usos en la diabetes. - Google Patents

Composiciones que comprenden compuestos de gastrina y sus usos en la diabetes.

Info

Publication number
MXPA05012605A
MXPA05012605A MXPA05012605A MXPA05012605A MXPA05012605A MX PA05012605 A MXPA05012605 A MX PA05012605A MX PA05012605 A MXPA05012605 A MX PA05012605A MX PA05012605 A MXPA05012605 A MX PA05012605A MX PA05012605 A MXPA05012605 A MX PA05012605A
Authority
MX
Mexico
Prior art keywords
compositions
diabetes
gastrin compounds
beneficial effects
gastrin
Prior art date
Application number
MXPA05012605A
Other languages
English (en)
Spanish (es)
Inventor
Antonio Cruz
Original Assignee
Waratah Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2003/016660 external-priority patent/WO2003100024A2/fr
Application filed by Waratah Pharmaceuticals Inc filed Critical Waratah Pharmaceuticals Inc
Publication of MXPA05012605A publication Critical patent/MXPA05012605A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MXPA05012605A 2003-05-27 2004-05-27 Composiciones que comprenden compuestos de gastrina y sus usos en la diabetes. MXPA05012605A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2003/016660 WO2003100024A2 (fr) 2002-05-24 2003-05-27 Traitement du diabete
PCT/CA2004/000769 WO2004105780A2 (fr) 2003-05-27 2004-05-27 Methodes et compositions contenant des composes de gastrine

Publications (1)

Publication Number Publication Date
MXPA05012605A true MXPA05012605A (es) 2006-02-22

Family

ID=33488788

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05012605A MXPA05012605A (es) 2003-05-27 2004-05-27 Composiciones que comprenden compuestos de gastrina y sus usos en la diabetes.

Country Status (11)

Country Link
EP (1) EP1648495A2 (fr)
JP (1) JP2007513059A (fr)
CN (1) CN1829528A (fr)
AU (1) AU2004243541A1 (fr)
BR (1) BRPI0410710A (fr)
CA (1) CA2527186A1 (fr)
MX (1) MXPA05012605A (fr)
NO (1) NO20055582L (fr)
PL (1) PL379145A1 (fr)
RU (1) RU2005140518A (fr)
WO (1) WO2004105780A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004520345A (ja) 2001-01-12 2004-07-08 ワラター・ファーマシューティカルズ・インク 糖尿病を有する被験者にガストリン／ｃｃｋ受容体リガンド及びｅｇｆ受容体リガンド組成物を用いた島細胞新生治療方法の効果持続
DE60329724D1 (de) 2002-06-07 2009-11-26 Waratah Pharmaceuticals Inc Methoden und Kompositionen um Diabetes zu behandeln
EP1837031B1 (fr) 2002-06-07 2009-10-14 Waratah Pharmaceuticals, Inc. Methodes et compositions pour le traitement du diabete
WO2005072045A2 (fr) * 2004-01-30 2005-08-11 Waratah Pharmaceuticals, Inc. Utilisation d'un agoniste de glp-1 associe a des composes gastriniques
US20100256061A1 (en) * 2007-03-02 2010-10-07 Antonio Cruz Gastrin compound for diabetes treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6558952B1 (en) * 1992-12-14 2003-05-06 Waratah Pharmaceuticals, Inc. Treatment for diabetes
WO1995019785A1 (fr) * 1994-01-24 1995-07-27 Research Triangle Pharmaceuticals Ltd. Traitement du diabete juvenile
JP2004520345A (ja) * 2001-01-12 2004-07-08 ワラター・ファーマシューティカルズ・インク 糖尿病を有する被験者にガストリン／ｃｃｋ受容体リガンド及びｅｇｆ受容体リガンド組成物を用いた島細胞新生治療方法の効果持続
DE60326002D1 (de) * 2002-10-22 2009-03-12 Waratah Pharmaceuticals Inc Behandlung von diabetes.

Also Published As

Publication number Publication date
BRPI0410710A (pt) 2006-06-13
WO2004105780A3 (fr) 2005-01-20
CN1829528A (zh) 2006-09-06
AU2004243541A1 (en) 2004-12-09
NO20055582D0 (no) 2005-11-25
JP2007513059A (ja) 2007-05-24
WO2004105780A2 (fr) 2004-12-09
RU2005140518A (ru) 2007-07-10
PL379145A1 (pl) 2006-07-24
NO20055582L (no) 2006-02-27
CA2527186A1 (fr) 2004-12-09
EP1648495A2 (fr) 2006-04-26

Similar Documents

Publication Publication Date Title
HK1079519A1 (en) Furyl compounds
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
GEP20125565B (en) Lactam compounds and their pharmaceutical use
IN2012DN02609A (fr)
HK1079522A1 (en) Thienyl compounds
IL180551A0 (en) Use of substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines in the treatment of nausea and vomiting
SG145694A1 (en) Novel compounds
MX2007005408A (es) Compuestos de aminoquinazolinas.
EP1551801A4 (fr) Nouveaux gamma-lactames en tant qu'inhibiteurs de la beta-secretase
TW200801001A (en) Compounds
TW200736263A (en) Compounds
TW200700071A (en) Novel use
MX2007006241A (es) 2-alcoxi-3,4,5-trihidroxi-alquilamidas, su preparacion, composiciones que las contienen y su utilizacion.
MX2007006042A (es) Bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparacion, composiciones que las contienen y utilizacion.
SG151306A1 (en) Novel benzothiazoles and the use thereof as medicaments
EP1667685A4 (fr) Inhibiteurs du canal potassique a base de quinazoline
TW200613308A (en) Cyclobutanetetracarboxylate compound and preparation method thereof
MX2007002917A (es) Todo-trans-retinol: todo-trans-13, 14-dihidrorretinol saturasa y metodos de uso de la misma.
IL175369A0 (en) Novel compound, corresponding compositions, preparation and/or treatment methods
TW200510398A (en) Novel compounds
MXPA06004308A (es) Isopentilcarboxanilidas para la lucha contra los microorganismos indeseables.
UA83203C2 (uk) Тіазол-(бі)циклоалкілкарбоксаніліди, засіб на їх основі та застосування для боротьби з небажаними мікроорганізмами
HK1091816A1 (en) Diphenylurea derivatives and their use as chloride channel blockers
GB0326633D0 (en) Therapeutic agents
NO20055582L (no) Preparater og fremgangsmater omfattende gastrinforbindelser

Legal Events

Date Code Title Description
FA Abandonment or withdrawal